Who owns Oncolytics Biotech Inc?
- Ticker: ONCY
- CUSIP Number: 682310875
Tip: Access positions for across all investors
Analyze quarterly positions in Oncolytics Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Oncolytics Biotech stock
Who bought or sold Oncolytics Biotech Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Seeds Investor | 190k | $165k | 0% | Sep 2024 |
|
| International Assets Investment Management | 174k | $200M | -12% | Sep 2024 |
|
| Morgan Stanley | 139k | $137k | -60% | Jun 2024 |
|
| Goldman Sachs Group | 84k | $83k | 0% | Jun 2024 |
|
| Citadel Advisors | 79k | $69k | -42% | Sep 2024 |
|
| Royal Bank of Canada | 75k | $0 | 20% | Sep 2024 |
|
| Commonwealth Equity Services | 61k | $53k | -3% | Sep 2024 |
|
| CIBC World Markets | 58k | $51k | 0% | Sep 2024 |
|
| Geode Capital Management | 42k | $37k | 0% | Sep 2024 |
|
| Long Focus Capital Management | 40k | $35k | 0% | Sep 2024 |
|
| SeaCrest Wealth Management | 26k | $23k | 100% | Sep 2024 |
|
| Brave Asset Management | 25k | $22k | 0% | Sep 2024 |
|
| Newman Dignan & Sheerar | 22k | $27k | 100% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 22k | $19k | -1% | Sep 2024 |
|
| Financial Advisory Corp | 21k | $18k | 100% | Sep 2024 |
|
| LPL Financial | 21k | $18k | 0% | Sep 2024 |
|
| Headinvest | 17k | $15k | 0% | Sep 2024 |
|
| Federation des caisses Desjardins du Quebec | 16k | $14k | 19% | Sep 2024 |
|
| C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors | 15k | $13k | 0% | Sep 2024 |
|
| Ausdal Financial Partners | 14k | $12k | -33% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 14k | $12k | 622% | Sep 2024 |
|
| Kingsview Wealth Management | 11k | $9.6k | 0% | Sep 2024 |
|
| PFG Investments | 11k | $10k | 0% | Jun 2024 |
|
| Creative Planning | 10k | $9.0k | 100% | Sep 2024 |
|
| Professional Advisory Services | 10k | $9.0k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 8.5k | $7.5k | -36% | Sep 2024 |
|
| Cedar Mountain Advisors | 5.7k | $4.9k | 0% | Sep 2024 |
|
| Activest Wealth Management | 5.0k | $4.4k | 0% | Sep 2024 |
|
| Wells Fargo & Company | 4.4k | $3.8k | 0% | Sep 2024 |
|
| Tower Research Capital | 3.2k | $3.2k | 100% | Jun 2024 |
|
| Principal Securities | 3.0k | $2.6k | 100% | Sep 2024 |
|
| IFP Advisors | 2.5k | $2.5k | 0% | Jun 2024 |
|
| Hanson McClain Advisors | 2.0k | $1.7k | 0% | Sep 2024 |
|
| Bank of America Corporation | 1.8k | $1.6k | 100% | Sep 2024 |
|
| CWM | 1.3k | $999.977500 | 0% | Sep 2024 |
|
| TD Waterhouse Canada | 557.00 | $481.025200 | -16% | Sep 2024 |
|
| JNBA Financial Advisors | 210.00 | $182.994000 | 0% | Sep 2024 |
|
| Aviso Financial | 56.00 | $54.997600 | 100% | Jun 2024 |
|
| Wolff Wiese Magana | 31.00 | $27.001000 | 0% | Sep 2024 |
|
Who sold out of Oncolytics Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Jun 2024 | 27k | $27k |
| Jane Street | Jun 2024 | 13k | $13k |
| Banque Cantonale Vaudoise | Jun 2024 | 12k | $12k |
| Two Sigma Securities | Mar 2024 | 12k | $13k |
| Toronto-Dominion Bank | Jun 2024 | 474.00 | $468.928200 |
| Pacifica Partners | Jun 2024 | 100.00 | $101.000000 |